Medicinal Chemistry Support Program for Therapeutic Development
Posted Date:
May 20, 2026
Jun 04, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| No Set aside used | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| HHSN271201800001I | Medicinal Chemistry Support Program for Therapeutic Development | |
| Synopsis | ||
|
INTRODUCTION PURSUANT TO RFO 5.101 — PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION. THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE MODIFICATION UNDER CONTRACT NO. HHSN271201800001I WITH CURIA GLOBAL, INC. The National Institute on Neurological Disorders and Stroke (NINDS) and the NIH Blueprint Neurotherapeutics Network (BPN) at the National Institutes of Health (NIH) intends to modify the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) Contract No. HHSN271201800001I “Medicinal Chemistry Support Program for Therapeutic Development” to increase the Single Award IDIQ maximum by $30,145,159 from $39,500,000 to $69,645,159 during the .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
